Table 2.
All Subjects (n = 587) | No or Mild BPD (n = 345) | Moderate or Severe BPD (n = 242) | P Value* | |
---|---|---|---|---|
Preexisting diabetes | 22 (3.7%) | 15 (4.3%) | 7 (2.9%) | 0.33 |
Gestational diabetes | 40 (6.8%) | 27 (7.8%) | 13 (5.4%) | 0.24 |
Preexisting hypertension | 67 (11.3%) | 37 (10.7%) | 30 (12.4%) | 0.55 |
Prolonged rupture of membranes | 107 (18.1%) | 64 (18.6%) | 43 (17.8%) | 0.86 |
Chorioamnionitis | 110 (18.6%) | 61 (17.7%) | 49 (20.2%) | 0.38 |
Preeclampsia | 154 (26.1%) | 98 (28.4%) | 56 (23.1%) | 0.17 |
Antepartum hemorrhage | 67 (11.3%) | 33 (9.6%) | 34 (14.0%) | 0.09 |
Maternal smoking | 80 (13.5%) | 35 (10.1%) | 45 (18.6%) | <0.01 |
Maternal alcohol use | 13 (2.2%) | 6 (1.7%) | 7 (2.9%) | 0.35 |
Maternal substance abuse | 50 (8.5%) | 27 (7.8%) | 23 (9.5%) | 0.47 |
Definition of abbreviation: BPD = bronchopulmonary dysplasia.
Descriptive statistics [count (percent)] are presented for maternal complications calculated for the entire study population, stratified by bronchopulmonary dysplasia severity. Univariate comparisons were made across bronchopulmonary dysplasia severity outcomes.
P value denotes comparison of last two columns.